# To Assess the Effect of 336 Days Exposure of Paractin® on Pain & Disease Progression in Patients Suffering From Osteoarthritis of Knee Joint.

> **NCT04833946** · NA · COMPLETED · sponsor: **Vedic Lifesciences Pvt. Ltd.** · enrollment: 80 (actual)

## Conditions studied

- Knee Osteoarthritis (Knee OA)

## Interventions

- **OTHER:** Andrographis paniculata [150 mg]
- **OTHER:** Microcrystalline Cellulose (MCC)

## Key facts

- **NCT ID:** NCT04833946
- **Lead sponsor:** Vedic Lifesciences Pvt. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-13
- **Primary completion:** 2024-02-20
- **Final completion:** 2024-02-20
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2025-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04833946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04833946, "To Assess the Effect of 336 Days Exposure of Paractin® on Pain & Disease Progression in Patients Suffering From Osteoarthritis of Knee Joint.". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04833946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*